semaglutide injection new market Novo Nordisk's weight-loss drug Wegovy could soon have a sales outlet in the U.S Type 2 diabetes: New Ozempic

Ponce, R

The drug produced dose-dependent weight loss but also dose-dependent GI side effects including nausea, vomiting, and diarrhea

The development of GLP-/GIP dual agonists provides a more complete scheme for the treatment of metabolic diseases, but the safety of more dual agonists or multiple agonists in clinical trials is also worthy of attention

Medicare is statutorily prohibited from covering obesity medications, and Congressional efforts to change that rule have been unsuccessful

Its important to check vitamin B12 levels often and adjust supplements as needed to avoid deficiency and health problems

Trial data